Association Between Mortality and Persistent Use of Beta Blockers and Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Coronary Artery Disease
To access this article, please choose from the options below
This work was supported in part by Grant U18HS10548 from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, Maryland.
PII: S0002-9149(09)00531-1
doi:10.1016/j.amjcard.2009.01.363
© 2009 Elsevier Inc. All rights reserved.
